Skip Content

PCRF research presented at top US conference

28 May 2013

Dr Yaohe Wang was invited to present the progress of his promising PCRF-funded research at the 16th Annual Meeting of the American Society of Gene and Cell Therapy in Salt Lake City on 18 May.

The 3-day international conference is a highly prestigious annual event, attended by over 1700 internationally renowned researchers. Being invited to present is a competitive process , and only a quarter of submitted research abstracts are selected.

Yaohe’s expertise is in virotherapy, an approach which uses viruses to infect cancer cells, leaving healthy cells unharmed.  His PCRF-funded project is looking to engineer the vaccinia virus into a vaccine to treat pancreatic cancer.  Dr Wang and key researcher Dr Louisa Chard, based at Barts Cancer Institute in London, are altering the vaccinia virus (which has already been safely engineered as a vaccine to prevent smallpox in millions of people) to express a therapeutic molecule with multiple anti-cancer properties once it infects cancer cells and results so far look promising.

Dr Wang believes that this research offers new hope for pancreatic cancer patients. He reported that his presentation was very well-received and he was extremely pleased to have the opportunity to discuss the project’s progress with colleagues from the international research community.  

< Back